Scavenging effects of dopamine agonists on nitric oxide radicals

Sakiko Nishibayashi, Masato Asanuma, Masahiro Kohno, Marvin Gómez-Vargas, Norio Ogawa

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

It has recently been considered that free radicals are closely involved in the pathogenesis of Parkinson's disease (PD), and the level of nitric oxide radical (·NO), one of the free radicals, is reported to increase in PD brain. In the present study, we established a direct detection system for ·NO in an in vitro ·NO generating system using 3-(2 hydroxy-1-methylethyl- 2-nitrosohydrazino)-N-methyl-1-propanamine as an ·NO donor and 2-(4- carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO) by electron spin resonance (ESR) spectrometry and examined the quenching effects of the dopamine agonists pergolide and bromocriptine on the amount of ·NO generated. ·NO appeared to be scavenged by pergolide and, to a lesser extent, by bromocriptine. In the competition assay, the 50% inhibitory concentration values for pergolide and bromocriptine were estimated to be ~23 and 200 μM, respectively. It was previously reported that in vivo treatment of pergolide and bromocriptine completely protected against the decrease in levels of striatal dopamine and its metabolites in the 6- hydroxydopamine-injected mouse. Considering these findings, pergolide and probably bromocriptine may also protect against dysfunction of dopaminergic neurons because of its multiple effects; not only does it stimulate the presynaptic autoreceptors, but it also directly scavenges ·NO radicals and hence protects against ·NO-related cytotoxicity. This ESR spectrometry method using carboxy-PTIO may be useful for screening other drugs that can quench ·NO.

Original languageEnglish
Pages (from-to)2208-2211
Number of pages4
JournalJournal of Neurochemistry
Volume67
Issue number5
Publication statusPublished - Nov 1996

Fingerprint

Dopamine Agonists
Scavenging
Pergolide
Nitric Oxide
Bromocriptine
Electron Spin Resonance Spectroscopy
Free Radicals
Parkinson Disease
Spectrum Analysis
Spectrometry
Paramagnetic resonance
Corpus Striatum
Autoreceptors
Preclinical Drug Evaluations
Nitric Oxide Donors
Oxidopamine
Dopaminergic Neurons
Cytotoxicity
Metabolites
Inhibitory Concentration 50

Keywords

  • 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3- oxide
  • Dopamine agonist
  • Electron spin resonance
  • Free radical
  • Nitric oxide
  • Pergolide
  • Scavenging effect

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Nishibayashi, S., Asanuma, M., Kohno, M., Gómez-Vargas, M., & Ogawa, N. (1996). Scavenging effects of dopamine agonists on nitric oxide radicals. Journal of Neurochemistry, 67(5), 2208-2211.

Scavenging effects of dopamine agonists on nitric oxide radicals. / Nishibayashi, Sakiko; Asanuma, Masato; Kohno, Masahiro; Gómez-Vargas, Marvin; Ogawa, Norio.

In: Journal of Neurochemistry, Vol. 67, No. 5, 11.1996, p. 2208-2211.

Research output: Contribution to journalArticle

Nishibayashi, S, Asanuma, M, Kohno, M, Gómez-Vargas, M & Ogawa, N 1996, 'Scavenging effects of dopamine agonists on nitric oxide radicals', Journal of Neurochemistry, vol. 67, no. 5, pp. 2208-2211.
Nishibayashi S, Asanuma M, Kohno M, Gómez-Vargas M, Ogawa N. Scavenging effects of dopamine agonists on nitric oxide radicals. Journal of Neurochemistry. 1996 Nov;67(5):2208-2211.
Nishibayashi, Sakiko ; Asanuma, Masato ; Kohno, Masahiro ; Gómez-Vargas, Marvin ; Ogawa, Norio. / Scavenging effects of dopamine agonists on nitric oxide radicals. In: Journal of Neurochemistry. 1996 ; Vol. 67, No. 5. pp. 2208-2211.
@article{fc0c452b00404f5e8b5c9920c67deedb,
title = "Scavenging effects of dopamine agonists on nitric oxide radicals",
abstract = "It has recently been considered that free radicals are closely involved in the pathogenesis of Parkinson's disease (PD), and the level of nitric oxide radical (·NO), one of the free radicals, is reported to increase in PD brain. In the present study, we established a direct detection system for ·NO in an in vitro ·NO generating system using 3-(2 hydroxy-1-methylethyl- 2-nitrosohydrazino)-N-methyl-1-propanamine as an ·NO donor and 2-(4- carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO) by electron spin resonance (ESR) spectrometry and examined the quenching effects of the dopamine agonists pergolide and bromocriptine on the amount of ·NO generated. ·NO appeared to be scavenged by pergolide and, to a lesser extent, by bromocriptine. In the competition assay, the 50{\%} inhibitory concentration values for pergolide and bromocriptine were estimated to be ~23 and 200 μM, respectively. It was previously reported that in vivo treatment of pergolide and bromocriptine completely protected against the decrease in levels of striatal dopamine and its metabolites in the 6- hydroxydopamine-injected mouse. Considering these findings, pergolide and probably bromocriptine may also protect against dysfunction of dopaminergic neurons because of its multiple effects; not only does it stimulate the presynaptic autoreceptors, but it also directly scavenges ·NO radicals and hence protects against ·NO-related cytotoxicity. This ESR spectrometry method using carboxy-PTIO may be useful for screening other drugs that can quench ·NO.",
keywords = "2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3- oxide, Dopamine agonist, Electron spin resonance, Free radical, Nitric oxide, Pergolide, Scavenging effect",
author = "Sakiko Nishibayashi and Masato Asanuma and Masahiro Kohno and Marvin G{\'o}mez-Vargas and Norio Ogawa",
year = "1996",
month = "11",
language = "English",
volume = "67",
pages = "2208--2211",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Scavenging effects of dopamine agonists on nitric oxide radicals

AU - Nishibayashi, Sakiko

AU - Asanuma, Masato

AU - Kohno, Masahiro

AU - Gómez-Vargas, Marvin

AU - Ogawa, Norio

PY - 1996/11

Y1 - 1996/11

N2 - It has recently been considered that free radicals are closely involved in the pathogenesis of Parkinson's disease (PD), and the level of nitric oxide radical (·NO), one of the free radicals, is reported to increase in PD brain. In the present study, we established a direct detection system for ·NO in an in vitro ·NO generating system using 3-(2 hydroxy-1-methylethyl- 2-nitrosohydrazino)-N-methyl-1-propanamine as an ·NO donor and 2-(4- carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO) by electron spin resonance (ESR) spectrometry and examined the quenching effects of the dopamine agonists pergolide and bromocriptine on the amount of ·NO generated. ·NO appeared to be scavenged by pergolide and, to a lesser extent, by bromocriptine. In the competition assay, the 50% inhibitory concentration values for pergolide and bromocriptine were estimated to be ~23 and 200 μM, respectively. It was previously reported that in vivo treatment of pergolide and bromocriptine completely protected against the decrease in levels of striatal dopamine and its metabolites in the 6- hydroxydopamine-injected mouse. Considering these findings, pergolide and probably bromocriptine may also protect against dysfunction of dopaminergic neurons because of its multiple effects; not only does it stimulate the presynaptic autoreceptors, but it also directly scavenges ·NO radicals and hence protects against ·NO-related cytotoxicity. This ESR spectrometry method using carboxy-PTIO may be useful for screening other drugs that can quench ·NO.

AB - It has recently been considered that free radicals are closely involved in the pathogenesis of Parkinson's disease (PD), and the level of nitric oxide radical (·NO), one of the free radicals, is reported to increase in PD brain. In the present study, we established a direct detection system for ·NO in an in vitro ·NO generating system using 3-(2 hydroxy-1-methylethyl- 2-nitrosohydrazino)-N-methyl-1-propanamine as an ·NO donor and 2-(4- carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO) by electron spin resonance (ESR) spectrometry and examined the quenching effects of the dopamine agonists pergolide and bromocriptine on the amount of ·NO generated. ·NO appeared to be scavenged by pergolide and, to a lesser extent, by bromocriptine. In the competition assay, the 50% inhibitory concentration values for pergolide and bromocriptine were estimated to be ~23 and 200 μM, respectively. It was previously reported that in vivo treatment of pergolide and bromocriptine completely protected against the decrease in levels of striatal dopamine and its metabolites in the 6- hydroxydopamine-injected mouse. Considering these findings, pergolide and probably bromocriptine may also protect against dysfunction of dopaminergic neurons because of its multiple effects; not only does it stimulate the presynaptic autoreceptors, but it also directly scavenges ·NO radicals and hence protects against ·NO-related cytotoxicity. This ESR spectrometry method using carboxy-PTIO may be useful for screening other drugs that can quench ·NO.

KW - 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3- oxide

KW - Dopamine agonist

KW - Electron spin resonance

KW - Free radical

KW - Nitric oxide

KW - Pergolide

KW - Scavenging effect

UR - http://www.scopus.com/inward/record.url?scp=0029845289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029845289&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 2208

EP - 2211

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -